Clinical Trial Update: Visnadine, Prenylflavonoids and Bovine Colostrum to Treat Vulvovaginal Atrophy in Postmenopausal Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating visnadine, prenylflavonoids, and bovine colostrum for vulvovaginal atrophy in postmenopausal women; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Vulvovaginal Atrophy

Drugs mentioned

• Bovine colostrum (bovine colostrum)
• Prenylflavonoids (Prenylflavonoids)
• Visnadine (Visnadine)

Snippet

Sponsor: University of Messina | Conditions: Vulvovaginal Atrophy, Menopause | Phase 2 | Status: COMPLETED